Advertiser / Brand
Pampers vs Revolution Beauty
Structured technology and market comparison · 2026
Direct Feature Comparison
Pampers · vs · Revolution BeautyBaby-care brand selling diapers and wipes under Procter & Gamble.
Public beauty brand selling makeup, skincare and haircare products.
Analyze all overlapping signals and tech stacks for Pampers and Revolution Beauty
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Pampers and Revolution Beauty?
When comparing Pampers and Revolution Beauty, both platforms operate within the Advertiser / Brand ecosystem. Pampers is positioned as Baby-care brand selling diapers and wipes under Procter & Gamble, whereas Revolution Beauty focuses on Public beauty brand selling makeup, skincare and haircare products. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Pampers and Revolution Beauty?
When evaluating Pampers and Revolution Beauty, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Pampers and Revolution Beauty compare?
Pampers is headquartered in US (founding year unrecorded) with Unknown. Revolution Beauty is based in GB (founded in 2014) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Pampers vs Revolution Beauty
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Pampers
Recent Signals
- ·SEC APIfinancials
10-K Financial Filing Analysis for Pampers (2026-08-04)
The Procter & Gamble Company reported its annual results for the fiscal year ended June 30, 2026, delivering net sales of $87.03 billion, up 3% year-over-year, supported by organic sales growth of 1%. Operating income decreased 3% to $19.75 billion due to a 100 bps reduction in gross margin (to 50.2%) driven by unfavorable product mix, increased commodity costs, and restructuring charges, alongside higher marketing expenditures. Net earnings attributable to P&G remained stable at $16.05 billion, with diluted EPS rising 2% to $6.62, aided by share repurchases and lower net non-operating costs. Cash generation remained robust, with operating cash flow reaching $19.56 billion and adjusted free cash flow productivity achieving 100%. Strategically, P&G continued executing its multi-year productivity and organizational restructuring program while expanding its portfolio, notably announcing the acquisition of Thorne for $3.8 billion.
- Net sales reached $87,032,000,000 in FY 2026, representing a 3% reported increase (1% organic growth), while operating income decreased 3% to $19,748,000,000.
- Net earnings attributable to Procter & Gamble were $16,046,000,000 ($6.62 diluted EPS, up 2%), with Core EPS reaching $6.89.
- Generated $19,556,000,000 in operating cash flow and $15,835,000,000 in adjusted free cash flow, while agreeing to acquire Thorne for $3.8 billion.
Revolution Beauty
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Revolution Beauty (2026-08-19)
On August 17, 2026, the Compensation Committee of Revelation Biosciences, Inc. approved material restricted stock grants to executive leadership under its Amended and Restated 2021 Equity Incentive Plan. Chief Executive Officer James Rolke received 208,076 restricted shares, and Chief Financial Officer Chester S. Zygmont, III was granted 208,073 restricted shares. The equity awards are structured to vest across four equal 25% tranches linked to either reaching market capitalization hurdles of $30 million, $60 million, $90 million, and $120 million for 20 consecutive trading days, or time-based vesting at the two-year and four-year marks. The package aligns executive compensation with aggressive market valuation targets while providing retention security.
- CEO James Rolke and CFO Chester S. Zygmont, III were granted 208,076 and 208,073 restricted shares, respectively, under the 2021 Equity Incentive Plan.
- Awards vest in four equal 25% tranches upon reaching market capitalization thresholds of $30M, $60M, $90M, and $120M sustained over 20 consecutive trading days, or alternatively at 2-year (first two tranches) and 4-year (final two tranches) time intervals.
- Grants include standard accelerated vesting protections upon a Change in Control or qualified involuntary termination events.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Pampers and Revolution Beauty share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks